Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Inspire Pharmaceuticals
Current Parent Company: Merck
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $6,000,000
Year: 2015
Date: June 18, 2015
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: Inspire Pharmaceuticals agreed to pay $6 million to settle multistate allegations that it violated state and federal False Claims Act laws by illegally marketing the drug Azasite for off-label uses not approved by the U.S. Food and Drug Administration. Also involved in the settlement was the federal government, which issued its own announcement; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.